1. Home
  2. KREF vs TSHA Comparison

KREF vs TSHA Comparison

Compare KREF & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KREF
  • TSHA
  • Stock Information
  • Founded
  • KREF 2014
  • TSHA 2019
  • Country
  • KREF United States
  • TSHA United States
  • Employees
  • KREF N/A
  • TSHA N/A
  • Industry
  • KREF Real Estate Investment Trusts
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KREF Real Estate
  • TSHA Health Care
  • Exchange
  • KREF Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • KREF 623.1M
  • TSHA 728.4M
  • IPO Year
  • KREF 2017
  • TSHA 2020
  • Fundamental
  • Price
  • KREF $9.23
  • TSHA $2.46
  • Analyst Decision
  • KREF Buy
  • TSHA Strong Buy
  • Analyst Count
  • KREF 8
  • TSHA 7
  • Target Price
  • KREF $12.22
  • TSHA $7.57
  • AVG Volume (30 Days)
  • KREF 665.1K
  • TSHA 5.2M
  • Earning Date
  • KREF 07-21-2025
  • TSHA 08-11-2025
  • Dividend Yield
  • KREF 10.83%
  • TSHA N/A
  • EPS Growth
  • KREF N/A
  • TSHA N/A
  • EPS
  • KREF 0.16
  • TSHA N/A
  • Revenue
  • KREF $97,478,000.00
  • TSHA $7,224,000.00
  • Revenue This Year
  • KREF $31.59
  • TSHA N/A
  • Revenue Next Year
  • KREF $7.29
  • TSHA N/A
  • P/E Ratio
  • KREF $56.76
  • TSHA N/A
  • Revenue Growth
  • KREF 93.07
  • TSHA N/A
  • 52 Week Low
  • KREF $8.28
  • TSHA $1.05
  • 52 Week High
  • KREF $12.95
  • TSHA $3.31
  • Technical
  • Relative Strength Index (RSI)
  • KREF 50.16
  • TSHA 45.90
  • Support Level
  • KREF $9.08
  • TSHA $2.48
  • Resistance Level
  • KREF $9.56
  • TSHA $2.66
  • Average True Range (ATR)
  • KREF 0.16
  • TSHA 0.21
  • MACD
  • KREF 0.02
  • TSHA -0.06
  • Stochastic Oscillator
  • KREF 60.12
  • TSHA 10.14

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: